Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,376 | -65,180 | -47,785 | -30,680 | -63,500 |
| Depreciation Amortization | 2,451 | 1,807 | 1,011 | 451 | 1,843 |
| Income taxes - deferred | 22 | 40 | 31 | 21 | 197 |
| Accounts receivable | 1,117 | 742 | -1,943 | -953 | -678 |
| Accounts payable and accrued liabilities | 796 | 994 | -324 | 9,339 | 99 |
| Other Working Capital | 3,839 | 5,260 | 4,718 | 10,444 | -4,451 |
| Other Operating Activity | 5,259 | 2,544 | 6,789 | -6,938 | 25,951 |
| Operating Cash Flow | $-70,892 | $-53,793 | $-37,503 | $-18,316 | $-40,539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -113 | -102 | -21 | -21 | -63 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 12,837 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,642 |
| Investing Cash Flow | $-113 | $-102 | $-21 | $-21 | $11,132 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 19,615 | 37,653 | N/A |
| Common Stock Issued | 106,762 | 106,686 | 39,428 | 172 | 40,990 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 3,794 |
| Financing Cash Flow | $106,762 | $106,686 | $59,043 | $37,825 | $44,784 |
| Beginning Cash Position | 19,106 | 19,106 | 19,106 | 19,106 | 3,729 |
| End Cash Position | 54,863 | 71,897 | 40,625 | 38,594 | 19,106 |
| Net Cash Flow | $35,757 | $52,791 | $21,519 | $19,488 | $15,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | -70,892 | -53,793 | -37,503 | -18,316 | -40,539 |
| Capital Expenditure | -113 | -102 | -21 | -21 | -63 |
| Free Cash Flow | -71,005 | -53,895 | -37,524 | -18,337 | -40,602 |